{
    "2021-10-01": [
        [
            {
                "time": "",
                "original_text": "营收净利润双升股价却跌超40% 健帆生物被“集采”和减持缠住手脚？ 盈利能力下降",
                "features": {
                    "keywords": [
                        "营收",
                        "净利润",
                        "股价下跌",
                        "健帆生物",
                        "集采",
                        "减持",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}